FDA Approval. EU Chmp recommendation for broad label...even EXPANDING on the drug
as we know it here to be in the U.S. ...Thousands of patients on this drug now....a 7000.00 per year..per patient drug. 22 years of DDEX patent life. A drug that really works wonders for patients as we've heard over and over again. VA collaberation now. All the other uses for this drug across 10 primary illnesses.
And a 3.19 stock price.
If someone had said to me before approval that that would be the case I would have said two things.
First...you're crazy. Totally insane. And SECOND...BUT..this Is the stock market we're talking about. Where crazy and insane things DO happen from time to time. That is after all what creates VALUE. I have a method of buying stocks that is very much like Warren Buffetts. I do my DD..EXTENSIVELY. Understand what it is i'm buying...what he future holds...what it's growth prospects are...and then I determine for myself what that is worth. And then i look at the stock price as it then stands and determine whether it is a VALUE.
I thought this was before FDA approval even. And now? it's off the charts folks. I mean..really..off the charts.
I look at stocks like ARNA...8.00 share for what? We have the REAL DEAL here...an honest to goodness fully approved enormous growth stock in the drug sector ahead of us. GROWTH..that will come from EARNINGS.
And i love that. I really do..It's not hype. Not pumping..not anything but solid fundamentals in which one can base future value.
In TWO years time we can be looking at 13,000 wk scripts between the US and EU. 13,000 per WEEK.
JUST for PBA.
Earnings are going to DRIVE THIS STOCK up....and up....and up. And up some more.
Earnings are going to make RayRim regret the DAY he ever heard the name Avanir.
Let me add this. That's just 2 years from now. WE are looking at 22 years....TWO DECADES of DDEX patent life. With many other uses. I simply do not know why we CAN'T see 50/share. 60/share. 80? 100?
GL to the short bashers. They're in a world of hurt.